| Dr Rachel Bates, OD | |
|
513 Beacon St, Apt 10, Boston, MA 02215-2309 | |
| (508) 620-0017 | |
| Not Available |
| Full Name | Dr Rachel Bates |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 10 Years |
| Location | 513 Beacon St, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164825428 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 5056 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ophthalmic Consultants Of Boston Inc | 4789651498 | 74 |
News Archive
Despite the global economic decline, Central and Eastern European (CEE) countries such as Poland, the Czech Republic, Slovakia, Hungary, Bulgaria and Romania still represent an attractive healthcare market.
While research has already established that B vitamin supplements can help slow mental decline in older people with memory problems, an international team have now found that having higher levels of Omega-3 fatty acids in your body could boost the B vitamins' effect.
Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane chemotherapy.
Composed of two different types of dopamine receptors, this novel target may have a significant role in understanding and treating schizophrenia.
› Verified 4 days ago
| Provider Name | Ophthalmic Consultants Of Boston Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1932146594 PECOS PAC ID: 4789651498 Enrollment ID: O20040913001012 |
News Archive
Despite the global economic decline, Central and Eastern European (CEE) countries such as Poland, the Czech Republic, Slovakia, Hungary, Bulgaria and Romania still represent an attractive healthcare market.
While research has already established that B vitamin supplements can help slow mental decline in older people with memory problems, an international team have now found that having higher levels of Omega-3 fatty acids in your body could boost the B vitamins' effect.
Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane chemotherapy.
Composed of two different types of dopamine receptors, this novel target may have a significant role in understanding and treating schizophrenia.
› Verified 4 days ago
| Provider Name | Associated Eye Surgeons |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1659338770 PECOS PAC ID: 7012982432 Enrollment ID: O20040921000542 |
News Archive
Despite the global economic decline, Central and Eastern European (CEE) countries such as Poland, the Czech Republic, Slovakia, Hungary, Bulgaria and Romania still represent an attractive healthcare market.
While research has already established that B vitamin supplements can help slow mental decline in older people with memory problems, an international team have now found that having higher levels of Omega-3 fatty acids in your body could boost the B vitamins' effect.
Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane chemotherapy.
Composed of two different types of dopamine receptors, this novel target may have a significant role in understanding and treating schizophrenia.
› Verified 4 days ago
| Provider Name | Eye Center Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1053429480 PECOS PAC ID: 2062416258 Enrollment ID: O20060830000368 |
News Archive
Despite the global economic decline, Central and Eastern European (CEE) countries such as Poland, the Czech Republic, Slovakia, Hungary, Bulgaria and Romania still represent an attractive healthcare market.
While research has already established that B vitamin supplements can help slow mental decline in older people with memory problems, an international team have now found that having higher levels of Omega-3 fatty acids in your body could boost the B vitamins' effect.
Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane chemotherapy.
Composed of two different types of dopamine receptors, this novel target may have a significant role in understanding and treating schizophrenia.
› Verified 4 days ago
| Provider Name | Dynamic Eye Care, Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1093905085 PECOS PAC ID: 0345332417 Enrollment ID: O20070821000086 |
News Archive
Despite the global economic decline, Central and Eastern European (CEE) countries such as Poland, the Czech Republic, Slovakia, Hungary, Bulgaria and Romania still represent an attractive healthcare market.
While research has already established that B vitamin supplements can help slow mental decline in older people with memory problems, an international team have now found that having higher levels of Omega-3 fatty acids in your body could boost the B vitamins' effect.
Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane chemotherapy.
Composed of two different types of dopamine receptors, this novel target may have a significant role in understanding and treating schizophrenia.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rachel Bates, OD 513 Beacon St, Apt 10, Boston, MA 02215-2309 Ph: (508) 620-0017 | Dr Rachel Bates, OD 513 Beacon St, Apt 10, Boston, MA 02215-2309 Ph: (508) 620-0017 |
News Archive
Despite the global economic decline, Central and Eastern European (CEE) countries such as Poland, the Czech Republic, Slovakia, Hungary, Bulgaria and Romania still represent an attractive healthcare market.
While research has already established that B vitamin supplements can help slow mental decline in older people with memory problems, an international team have now found that having higher levels of Omega-3 fatty acids in your body could boost the B vitamins' effect.
Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane chemotherapy.
Composed of two different types of dopamine receptors, this novel target may have a significant role in understanding and treating schizophrenia.
› Verified 4 days ago
Dr. Ying Zhou, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1341 Boylston St, Target Optical, Boston, MA 02215 Phone: 857-654-5912 | |
Justine Pidgeon, OD Optometrist Medicare: Medicare Enrolled Practice Location: 400 Commonwealth Ave Ste 2, Boston, MA 02215 Phone: 617-426-0370 | |
Dr. Brittney Jaye Mazza, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 930 Commonwealth Ave, Suite 2a, Boston, MA 02215 Phone: 617-262-2020 | |
Boston Telehealth Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 424 Beacon St, Boston, MA 02115 Phone: 617-834-3245 | |
Ms. Ceida P Chan, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 780 Albany St, Boston, MA 02118 Phone: 857-654-1000 Fax: 857-654-1100 | |
Dr. Howard S Harrison, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 33 Broad St, Lobby, Boston, MA 02109 Phone: 617-742-7200 Fax: 617-742-7272 | |
Dr. Doug Rett, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 150 S Huntington Ave, Optometry 8th Floor, Boston, MA 02130 Phone: 617-548-9208 |